In clinical trials , Zepbound produced weight loss results of 15%21% in 72 weeks (about a year and five months)
Brindisi M-C, Brondel L, Meillon S, Barthet S, Grall S, Fenech C, et al
Notably, the STEP TEENS trial showed that semaglutide 2.4 mg, administered once weekly via subcutaneous injection, can be used in individuals aged 12 years and older, as adolescents with obesity treated with semaglutide experienced a significant reduction in BMI compared with placebo, along with improvements in several cardiometabolic risk factors [47]
Maintains memory recall in elderly individuals
It belongs to a class of medicines called glucagon-like peptide-1 (GLP-1) receptor agonists , which work by mimicking the action of a naturally occurring hormone that regulates blood sugar levels